CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo

Autor: Kathryn S. Leung, Sharon Lam, Helen E. Heslop, Elizabeth J. Shpall, Cliona M. Rooney, Sarah Nikiforow, Hao Liu, Phillip Scheinberg, Caridad Martinez, Catherine M. Bollard, Gail J. Demmler-Harrison, John R. Rodgers, Patrick J. Hanley, J. Joseph Melenhorst, Robert A. Krance, C. Russell Cruz, James W Blaney, Daniel C. Douek, A. John Barrett
Rok vydání: 2015
Předmět:
Zdroj: Science Translational Medicine. 7
ISSN: 1946-6242
1946-6234
DOI: 10.1126/scitranslmed.aaa2546
Popis: Adoptive transfer of cytomegalovirus (CMV)-specific T cells derived from adult seropositive donors can effectively restore antiviral immunity after transplantation. However, CMV-seronegative donors lack CMV-specific memory T cells, which restricts the availability of virus-specific T cells for immunoprophylaxis. We demonstrate the feasibility of deriving CMV-specific T cells from naïve cells for T cell therapy. Naïve T cells primed to recognize CMV were restricted to different, atypical epitopes than T cells derived from CMV-seropositive individuals; however, these two cell populations had similar avidities. CMV-seropositive individuals also had T cells recognizing these atypical epitopes, but these cells had a lower avidity than those derived from the seronegative subjects, which suggests that high-avidity T cells to these epitopes may be lost over time. Indeed, recipients of cord blood (CB) grafts who did not develop CMV were found by clonotypic analysis to have T cells recognizing atypical CMVpp65 epitopes. Therefore, we examined unmanipulated CB units and found that T cells with T cell receptors restricted by atypical epitopes were the most common, which may explain why these T cells expanded. When infused to recipients, naïve donor-derived virus-specific T cells that recognized atypical epitopes were associated with prolonged periods of CMV-free survival and complete remission. These data suggest that naïve-derived T cells from seronegative patients may be an additional source of cells for CMV immunoprophylaxis.
Databáze: OpenAIRE